A Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Subjects With Active Axial Spondyloarthritis Including Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Clinical trial NCT04436640 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04436640
- Sponsor
- UCB Biopharma SRL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2026-08-07
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.